The NT-proBNP level is recommended by guidelines as the most valuable and reliable biomarker for the diagnosis of HF(Ponikowski et al., 2016), and is widely used for differential diagnosis, risk stratification and prognostic assessment of CHF. This evidence concerns the gene NPPB and hydrops fetalis.